FFX

APi Group Reports Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 2, 2023

Our goal of evolving away from lower margin, higher risk opportunities while focusing investments on service revenue expansion is yielding the desired results.

Key Points: 
  • Our goal of evolving away from lower margin, higher risk opportunities while focusing investments on service revenue expansion is yielding the desired results.
  • The benefit of these initiatives is shown in APi’s consistently strong and improving financial results.
  • These results are built on a strong foundation of driving the Company’s recurring revenue, services-focused business model while expanding the financial discipline of the organization and its leadership team.
  • You may also attend and view the presentation (live or by replay) via webcast by accessing the following URL:

Nortech Systems Announces Patent for Flexible Faraday Cage Printed Circuit Board and Cable

Retrieved on: 
Thursday, August 25, 2022

11,412,608, for the Companys Flex Faraday Xtreme, a flexible printed circuit for transmitting high frequency signals while precisely controlling both crosstalk and impedance, minimizing electromagnetic interference, improving parallel transmission alignment, and increasing data density.

Key Points: 
  • 11,412,608, for the Companys Flex Faraday Xtreme, a flexible printed circuit for transmitting high frequency signals while precisely controlling both crosstalk and impedance, minimizing electromagnetic interference, improving parallel transmission alignment, and increasing data density.
  • View the full release here: https://www.businesswire.com/news/home/20220825005696/en/
    Nortech Systems' Flex Faraday Xtreme (FFX) is a flexible printed circuit for transmitting high frequency signals while precisely controlling both crosstalk and impedance, minimizing electromagnetic interference, improving parallel transmission alignment, and increasing data density.
  • With FFX, Nortech provides intelligent transmission lines that provide benefits over traditional micro coax cables in challenging applications.
  • Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components.

Proactive news headlines including C29 Metals Ltd, Krakatoa Resources, Flynn Gold and Chimeric Therapeutics

Retrieved on: 
Tuesday, July 5, 2022

Click here

Key Points: 
  • Click here
    Krakatoa Resources Ltd (ASX:KTA) has wrapped up resource drilling at its 100%-owned Dalgaranga Critical Metals Project, around 70 kilometres from Mt Magnet in WA.
  • Click here
    Chimeric Therapeutics Ltd (ASX:CHM) has strengthened its management team with the appointment of experienced pharma executive Cassandra Harrison as vice president of Clinical Operations and Data Management.
  • Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.
  • For more information on how Proactive can help you make a difference, email us at [email protected]

Proactive news headlines including Infinity Lithium Corporation, OzAurum Resources, Anteris Technologies and Nova Minerals

Retrieved on: 
Tuesday, May 31, 2022

Click here

Key Points: 
  • Click here
    Nova Minerals Ltd (ASX:NVA, OTCQB:NVAAF) is on its way to shaping North Americas next major gold trend as it advances the cornerstone Estelle Gold Project.
  • Click here
    Tempus Resources Ltd (ASX:TMR, TSX-V:TMRR) has kicked off its 2022 exploration campaign at the Elizabeth Gold Project in southern British Columbia, Canada.
  • Click here
    Firefinch Ltd (ASX:FFX) continues to move its demerger forward with Leo Lithium closing an Initial Public Offering (IPO) oversubscribed having raised A$100 million.
  • For more information on how Proactive can help you make a difference, email us at [email protected]

Proactive news headlines including AVZ Minerals, European Lithium, Latin Resources and Calima Energy

Retrieved on: 
Friday, April 1, 2022

Click here

Key Points: 
  • Click here
    European Lithium Ltd (ASX:EUR, OTCQB:EULIF) is encouraged by todays announcement by its partner, battery metals explorer EV Resources, outlining its Austrian lithium exploration and evaluation strategy.
  • Click here
    Calima Energy Ltd (ASX:CE1) has strengthened its board skillset with the appointment of experienced oil and gas engineer Karl Lawrence DeMong to the position of non-executive director.
  • Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.
  • For more information on how Proactive can help you make a difference, email us at [email protected]

Rafael Holdings Provides Update on Rafael Pharmaceuticals’ Two Phase 3 Trials of CPI-613® (Devimistat), AVENGER 500 in Metastatic Pancreatic Cancer and ARMADA 2000 in Relapsed or Refractory Acute Myeloid Leukemia

Retrieved on: 
Thursday, October 28, 2021

NEWARK, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc., (NYSE: RFL), a holding company focused on developing novel cancer metabolism therapeutics through its Barer Institute, investment in Rafael Pharmaceuticals, Inc. (“Rafael Pharmaceuticals”) as well as other investments in early-stage ventures, today announced that the AVENGER 500 Phase 3 clinical trial for CPI-613® (devimistat), Rafael Pharmaceuticals’ lead product candidate, did not meet its primary endpoint of significant improvement in overall survival in patients with metastatic adenocarcinoma of the pancreas.

Key Points: 
  • The median overall survival in the treatment arm was 11.1 months, compared to 11.7 months in the control arm.
  • Devimistat is also being evaluated in a multi-national Phase 3 randomized clinical trial, ARMADA 2000, in patients with relapsed or refractory acute myeloid leukemia (AML).
  • Following a pre-specified interim analysis, the independent data monitoring committee has recommended the trial be stopped due to lack of efficacy.
  • The European Medicines Agency (EMA) has granted orphan drug designation to devimistat for pancreatic cancer, acute myeloid leukemia and Burkitts lymphoma.

Proactive news headlines including AVZ Minerals, Imugene, MMJ Group Holdings and Blue Star Helium

Retrieved on: 
Wednesday, October 20, 2021

Click here

Key Points: 
  • Click here
    Imugene Limited (ASX:IMU, OTC:IUGNF) collaborator City of Hope has dosed its first patient in its Phase I clinical trial of oncolytic virotherapy candidate, CHECKvacc.
  • Click here
    MMJ Group Holdings Ltd (ASX:MMJ, OTC:MMJJF)s portfolio companies continue to execute on their business plans and are in a better financial position than they were a year ago.
  • Click here
    Blue Star Helium Ltd (ASX:BNL, OTC:AZZEF) has progressed a water well drilling program designed to provide water to local ranch holders and generate new data near its Las Animas landholdings in Colorado.
  • Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006
    For more information on how Proactive can help you make a difference, email us at [email protected]